Title |
Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
|
---|---|
Published in |
Cardiovascular Drugs and Therapy, February 2019
|
DOI | 10.1007/s10557-019-06852-6 |
Pubmed ID | |
Authors |
Henry N. Ginsberg, Jaakko Tuomilehto, G. Kees Hovingh, Bertrand Cariou, Raul D. Santos, Alan S. Brown, Santosh K. Sanganalmath, Andrew Koren, Desmond Thompson, Frederick J. Raal |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 56% |
Romania | 2 | 22% |
France | 1 | 11% |
Finland | 1 | 11% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 44% |
Scientists | 3 | 33% |
Science communicators (journalists, bloggers, editors) | 1 | 11% |
Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 72 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 10 | 14% |
Researcher | 8 | 11% |
Student > Master | 6 | 8% |
Other | 5 | 7% |
Student > Ph. D. Student | 5 | 7% |
Other | 10 | 14% |
Unknown | 28 | 39% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 27 | 38% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 8% |
Biochemistry, Genetics and Molecular Biology | 4 | 6% |
Veterinary Science and Veterinary Medicine | 1 | 1% |
Arts and Humanities | 1 | 1% |
Other | 2 | 3% |
Unknown | 31 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 February 2019.
All research outputs
#6,311,196
of 23,128,387 outputs
Outputs from Cardiovascular Drugs and Therapy
#152
of 701 outputs
Outputs of similar age
#133,553
of 439,824 outputs
Outputs of similar age from Cardiovascular Drugs and Therapy
#4
of 17 outputs
Altmetric has tracked 23,128,387 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 701 research outputs from this source. They receive a mean Attention Score of 5.0. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.